These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


248 related items for PubMed ID: 18453259

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H, Zhao K, Wang L, Zheng Y, Zhang G, Mai H, Han Y, Yang L, Guo S.
    J Surg Res; 2010 May 15; 160(2):315-24. PubMed ID: 19524257
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mesenchymal stem cells can affect solid organ allograft survival.
    Popp FC, Eggenhofer E, Renner P, Geissler EK, Piso P, Schlitt HJ, Dahlke MH.
    Transplantation; 2009 May 15; 87(9 Suppl):S57-62. PubMed ID: 19424009
    [Abstract] [Full Text] [Related]

  • 8. Mesenchymal stromal cells.
    Bernardo ME, Locatelli F, Fibbe WE.
    Ann N Y Acad Sci; 2009 Sep 15; 1176():101-17. PubMed ID: 19796238
    [Abstract] [Full Text] [Related]

  • 9. Immune modulation by mesenchymal stem cells.
    Rasmusson I.
    Exp Cell Res; 2006 Jul 15; 312(12):2169-79. PubMed ID: 16631737
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mesenchymal stem cells in osteoarticular diseases.
    Jorgensen C, Noël D.
    Regen Med; 2011 Nov 15; 6(6 Suppl):44-51. PubMed ID: 21999261
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A role for mesenchymal stem cells in the control of graft-versus-host disease.
    Cohen JL, Sudres M.
    Transplantation; 2009 May 15; 87(9 Suppl):S53-4. PubMed ID: 19424007
    [Abstract] [Full Text] [Related]

  • 16. Immunological properties of mesenchymal stem cells and clinical implications.
    Patel SA, Sherman L, Munoz J, Rameshwar P.
    Arch Immunol Ther Exp (Warsz); 2008 May 15; 56(1):1-8. PubMed ID: 18250975
    [Abstract] [Full Text] [Related]

  • 17. Immunomodulation by mesenchymal stem cells and clinical experience.
    Le Blanc K, Ringdén O.
    J Intern Med; 2007 Nov 15; 262(5):509-25. PubMed ID: 17949362
    [Abstract] [Full Text] [Related]

  • 18. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
    Nasef A, Mathieu N, Chapel A, Frick J, François S, Mazurier C, Boutarfa A, Bouchet S, Gorin NC, Thierry D, Fouillard L.
    Transplantation; 2007 Jul 27; 84(2):231-7. PubMed ID: 17667815
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Therapeutic potential of genetically modified mesenchymal stem cells.
    Kumar S, Chanda D, Ponnazhagan S.
    Gene Ther; 2008 May 27; 15(10):711-5. PubMed ID: 18356815
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.